(CCJ) Cameco - Ratings and Ratios
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA13321L1085
CCJ: Uranium, Fuel, Reactors, Services, Technology
Cameco Corporation (NYSE:CCJ) is a leading global uranium producer, operating through three primary segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment focuses on the exploration, mining, milling, and sale of uranium concentrate, with key operations in Canada and Kazakhstan. The Fuel Services segment, based in Ontario, specializes in refining, converting, and fabricating uranium, enhancing the value chain for nuclear fuel. The Westinghouse segment, a prominent nuclear reactor technology company, offers outage services, engineering support, and reactor components globally. Camecos products and services are distributed to nuclear utilities across the Americas, Europe, and Asia, solidifying its position in the nuclear energy sector. Incorporated in 1987 and headquartered in Saskatoon, Canada, Cameco is strategically positioned to meet the growing demand for clean energy solutions.
Based on the provided data, Camecos stock is currently trading below its 20, 50, and 200-day Simple Moving Averages (SMA), indicating a bearish trend. The stock price of $39.61 is below the SMA 20 of $40.99, SMA 50 of $43.17, and SMA 200 of $47.76. The Average True Range (ATR) of 2.00 suggests moderate volatility. The average 20-day volume is 3,108,302 shares, indicating consistent trading activity. Fundamental analysis shows a market cap of $17,926.15M USD, with a high P/E ratio of 147.07, though the forward P/E is more favorable at 48.54. The P/B ratio of 3.93 and P/S ratio of 5.72 reflect a premium valuation, while the RoE of 2.70% indicates lower profitability. Over the next three months, Camecos stock is expected to face short-term weakness due to technical resistance levels at $47.4, $48.9, and $51.2. However, strategic demand-driven production adjustments and potential improvements in uranium market fundamentals could position the company for long-term recovery and growth.
Additional Sources for CCJ Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CCJ Stock Overview
Market Cap in USD | 19,149m |
Sector | Energy |
Industry | Uranium |
GiC Sub-Industry | Coal & Consumable Fuels |
IPO / Inception | 1996-03-14 |
CCJ Stock Ratings
Growth Rating | 70.2 |
Fundamental | 28.7 |
Dividend Rating | 54.5 |
Rel. Strength | 3.87 |
Analysts | 4.53/5 |
Fair Price Momentum | 47.07 USD |
Fair Price DCF | 15.47 USD |
CCJ Dividends
Dividend Yield 12m | 0.24% |
Yield on Cost 5y | 1.13% |
Annual Growth 5y | 13.32% |
Payout Consistency | 94.2% |
CCJ Growth Ratios
Growth Correlation 3m | -69.3% |
Growth Correlation 12m | -19.4% |
Growth Correlation 5y | 94.6% |
CAGR 5y | 35.02% |
CAGR/Max DD 5y | 0.88 |
Sharpe Ratio 12m | -0.19 |
Alpha | -21.69 |
Beta | 1.633 |
Volatility | 50.55% |
Current Volume | 2444.2k |
Average Volume 20d | 3241.8k |
As of April 30, 2025, the stock is trading at USD 45.42 with a total of 2,444,201 shares traded.
Over the past week, the price has changed by +13.04%, over one month by +10.35%, over three months by -9.29% and over the past year by -7.91%.
Neither. Based on ValueRay Fundamental Analyses, Cameco is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.67 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCJ as of April 2025 is 47.07. This means that CCJ is currently overvalued and has a potential downside of 3.63%.
Cameco has received a consensus analysts rating of 4.53. Therefor, it is recommend to buy CCJ.
- Strong Buy: 10
- Buy: 9
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CCJ Cameco will be worth about 54.5 in April 2026. The stock is currently trading at 45.42. This means that the stock has a potential upside of +19.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 58.4 | 28.5% |
Analysts Target Price | 58.4 | 28.6% |
ValueRay Target Price | 54.5 | 19.9% |